Correlation Between Decibel Cannabis and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Decibel Cannabis and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Decibel Cannabis and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Decibel Cannabis and Pfizer Inc CDR, you can compare the effects of market volatilities on Decibel Cannabis and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Decibel Cannabis with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Decibel Cannabis and Pfizer.

Diversification Opportunities for Decibel Cannabis and Pfizer

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Decibel and Pfizer is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Decibel Cannabis and Pfizer Inc CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc CDR and Decibel Cannabis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Decibel Cannabis are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc CDR has no effect on the direction of Decibel Cannabis i.e., Decibel Cannabis and Pfizer go up and down completely randomly.

Pair Corralation between Decibel Cannabis and Pfizer

Given the investment horizon of 90 days Decibel Cannabis is expected to generate 4.3 times more return on investment than Pfizer. However, Decibel Cannabis is 4.3 times more volatile than Pfizer Inc CDR. It trades about 0.0 of its potential returns per unit of risk. Pfizer Inc CDR is currently generating about -0.06 per unit of risk. If you would invest  13.00  in Decibel Cannabis on September 2, 2024 and sell it today you would lose (6.50) from holding Decibel Cannabis or give up 50.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Decibel Cannabis  vs.  Pfizer Inc CDR

 Performance 
       Timeline  
Decibel Cannabis 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Decibel Cannabis are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Decibel Cannabis showed solid returns over the last few months and may actually be approaching a breakup point.
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Pfizer is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Decibel Cannabis and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Decibel Cannabis and Pfizer

The main advantage of trading using opposite Decibel Cannabis and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Decibel Cannabis position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind Decibel Cannabis and Pfizer Inc CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Fundamental Analysis
View fundamental data based on most recent published financial statements
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins